OptimizeRx OPRX Stock
OptimizeRx Price Chart
OptimizeRx OPRX Financial and Trading Overview
OptimizeRx stock price | 11.65 USD |
Previous Close | 15.01 USD |
Open | 14.98 USD |
Bid | 0 USD x 1200 |
Ask | 0 USD x 1100 |
Day's Range | 14.9 - 15.11 USD |
52 Week Range | 11.59 - 30.82 USD |
Volume | 62.06K USD |
Avg. Volume | 203.73K USD |
Market Cap | 257.26M USD |
Beta (5Y Monthly) | 0.977112 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.84 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 21.5 USD |
OPRX Valuation Measures
Enterprise Value | 183.6M USD |
Trailing P/E | N/A |
Forward P/E | 38.51282 |
PEG Ratio (5 yr expected) | 2.5 |
Price/Sales (ttm) | 4.1680436 |
Price/Book (mrq) | 2.0740128 |
Enterprise Value/Revenue | 2.975 |
Enterprise Value/EBITDA | -13.525 |
Trading Information
OptimizeRx Stock Price History
Beta (5Y Monthly) | 0.977112 |
52-Week Change | -43.99% |
S&P500 52-Week Change | 20.43% |
52 Week High | 30.82 USD |
52 Week Low | 11.59 USD |
50-Day Moving Average | 14.21 USD |
200-Day Moving Average | 16.07 USD |
OPRX Share Statistics
Avg. Volume (3 month) | 203.73K USD |
Avg. Daily Volume (10-Days) | 101.47K USD |
Shares Outstanding | 17.13M |
Float | 16.35M |
Short Ratio | 4.92 |
% Held by Insiders | 4.55% |
% Held by Institutions | 81.44% |
Shares Short | 722.08K |
Short % of Float | 4.38% |
Short % of Shares Outstanding | 4.21% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:3 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -22.80% |
Operating Margin (ttm) | -25.26% |
Gross Margin | 62.04% |
EBITDA Margin | -21.99% |
Management Effectiveness
Return on Assets (ttm) | -7.22% |
Return on Equity (ttm) | -11.038% |
Income Statement
Revenue (ttm) | 61.72M USD |
Revenue Per Share (ttm) | 3.51 USD |
Quarterly Revenue Growth (yoy) | -5.29% |
Gross Profit (ttm) | 38.97M USD |
EBITDA | -13575074 USD |
Net Income Avi to Common (ttm) | -14075056 USD |
Diluted EPS (ttm) | -0.8 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 73.7M USD |
Total Cash Per Share (mrq) | 4.3 USD |
Total Debt (mrq) | 212.51K USD |
Total Debt/Equity (mrq) | 0.17 USD |
Current Ratio (mrq) | 12.607 |
Book Value Per Share (mrq) | 7.242 |
Cash Flow Statement
Operating Cash Flow (ttm) | 6.49M USD |
Levered Free Cash Flow (ttm) | 11.22M USD |
Profile of OptimizeRx
Country | United States |
State | MI |
City | Rochester |
Address | 400 Water Street |
ZIP | 48307 |
Phone | 248 651 6568 |
Website | https://www.optimizerx.com |
Industry | Health Information Services |
Sector(s) | Healthcare |
Full Time Employees | 109 |
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow. The company also offers Social Network Banner Messaging solution to deliver banner messaging to HCPs within their social network apps; Institutional Account-based Banner Messaging solution that provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts; and Financial Messaging solution, which provides prescribers visibility to branded copay offers and other patient support programs directly within their electronic health record and/or e-Prescribe systems. In addition, it provides Patient Engagement, a technology solution that provides digital messaging services through its cloud-based Mobile Health Messenger platform; HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance; and Therapy Initiation Workflow, a group of digital solutions that focuses on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was founded in 2006 and is headquartered in Rochester, Michigan.
Q&A For OptimizeRx Stock
What is a current OPRX stock price?
OptimizeRx OPRX stock price today per share is 11.65 USD.
How to purchase OptimizeRx stock?
You can buy OPRX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for OptimizeRx?
The stock symbol or ticker of OptimizeRx is OPRX.
Which industry does the OptimizeRx company belong to?
The OptimizeRx industry is Health Information Services.
How many shares does OptimizeRx have in circulation?
The max supply of OptimizeRx shares is 18.5M.
What is OptimizeRx Price to Earnings Ratio (PE Ratio)?
OptimizeRx PE Ratio is now.
What was OptimizeRx earnings per share over the trailing 12 months (TTM)?
OptimizeRx EPS is -0.84 USD over the trailing 12 months.
Which sector does the OptimizeRx company belong to?
The OptimizeRx sector is Healthcare.
OptimizeRx OPRX included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 18737.21 USD — |
-1
|
7.88B USD — | 18599.69 USD — | 18841.52 USD — | — - | 7.88B USD — |
Nasdaq Industrial INDS | 11674.94 USD — |
-0.64
|
— — | 11572.59 USD — | 11729.51 USD — | — - | — — |
NASDAQ Capital Market Composite RCMP | 112.43 USD — |
+0.26
|
— — | 109.69 USD — | 112.55 USD — | — - | — — |
Nasdaq Health Care IXHC | 932.02 USD — |
-0.03
|
— — | 920.46 USD — | 933.54 USD — | — - | — — |
- {{ link.label }} {{link}}